| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3358184 | Inmunología | 2014 | 5 Pages |
Abstract
Risk factors for developing an evolving phenotype in MGUS patients are the same as those already described for the development of MM. These data show the validity of the evolving/non-evolving model to study markers to predict the outcome of MGUS patients, and confirm the role of the levels of monoclonal IgG and the light chains ratio in the prognosis of this disease.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Silvia Medina, Mercedes Espiño, MarÃa J. Blanchard, Raquel Alenda, Ernesto Roldán, Luisa M. Villar,